Skip to main content

 

LITTLE ROCK, Ark., March 08, 2024 — Inuvo, Inc. (NYSE American: INUV), a leading provider of advertising technology, powered by artificial intelligence (AI) that serves brands and agencies, announced today that it will be participating in the iAccess Alpha Buyside Best Ideas Spring Conference 2024 being held virtually on March 12th and 13th, 2024.

Richard Howe, Chief Executive Officer of Inuvo, is scheduled to present on Tuesday, March 12th at 9:30 a.m. Eastern Standard Time. To register and access the presentation, please visit Inuvo Inc (INUV) (webcaster4.com).

Mr. Howe will also be available for one-on-one meetings with approved qualified investors on Wednesday, March 13th. To register for a one-on-one meeting, please visit the conference website at https://www.iaccessalpha.com/home.

iAccess Alpha hosts virtual investor conferences, where presenting companies are recommended by a network of investors. The conference format spans two days, with company webcast presentations on day one, followed by one-on-one meetings with company management teams on day two.

About Inuvo

Inuvo®, Inc. (NYSE American: INUV) is a market leader in Artificial Intelligence built for advertising. Its IntentKey AI solution is a first-of-its-kind proprietary and patented technology capable of identifying and actioning to the reasons why consumers are interested in products, services, or brands, not who those consumers are. To learn more, visit www.inuvo.com.

Safe Harbor / Forward-Looking Statements

 

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Inuvo’s quarter-end financial close process and preparation of financial statements for the quarter that are subject to risks and uncertainties that could cause results to be materially different than expectations. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including, without limitation risks detailed from time to time in our filings with the Securities and Exchange Commission (the “SEC”), and represent our views only as of the date they are made and should not be relied upon as representing our views as of any subsequent date. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in Inuvo, Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 as filed on March 10, 2023, and our other filings with the SEC. Additionally, forward looking statements are subject to certain risks, trends, and uncertainties including the continued impact of Covid-19 on Inuvo’s business and operations. Inuvo cannot provide assurances that the assumptions upon which these forward-looking statements are based will prove to have been correct. Should one of these risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those expressed or implied in any forward-looking statements, and investors are cautioned not to place undue reliance on these forward-looking statements, which are current only as of this date. Inuvo does not intend to update or revise any forward-looking statements made herein or any other forward-looking statements as a result of new information, future events or otherwise. Inuvo further expressly disclaims any written or oral statements made by a third-party regarding the subject matter of this press release. The information which appears on our websites and our social media platforms is not part of this press release.

Inuvo Company Contact:

Wally Ruiz

Chief Financial Officer

Tel (501) 205-8397

wallace.ruiz@inuvo.com

Investor Relations :

David Waldman / Natalya Rudman

Crescendo Communications, LLC

Tel: (212) 671-1020

inuv@crescendo-ir.com


Primary Logo

Close Menu
   

Inuvo Inc

Corporate HQ

500 President Clinton Ave #300
Little Rock, AR, 72201

Engineering HQ

3031 Tisch Way, Ste. 400 San Jose, CA 95128

Inuvo®